APA (7th ed.) Citation

Ahmad, R., Postnov, A., Bormans, G., Versijpt, J., Vandenbulcke, M., & Laere, K. (2016). Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease. European Journal of Nuclear Medicine & Molecular Imaging, 43(12), 2219. https://doi.org/10.1007/s00259-016-3457-7

Chicago Style (17th ed.) Citation

Ahmad, Rawaha, Andrey Postnov, Guy Bormans, Jan Versijpt, Mathieu Vandenbulcke, and Koen Laere. "Decreased in Vivo Availability of the Cannabinoid Type 2 Receptor in Alzheimer's Disease." European Journal of Nuclear Medicine & Molecular Imaging 43, no. 12 (2016): 2219. https://doi.org/10.1007/s00259-016-3457-7.

MLA (9th ed.) Citation

Ahmad, Rawaha, et al. "Decreased in Vivo Availability of the Cannabinoid Type 2 Receptor in Alzheimer's Disease." European Journal of Nuclear Medicine & Molecular Imaging, vol. 43, no. 12, 2016, p. 2219, https://doi.org/10.1007/s00259-016-3457-7.